Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Brain stimulation study for speech and arm movement after subcortical stroke

Tests deep brain stimulation to aid hand, arm and speech recovery in adults after stroke.

Plain-language title generated from the registry record
Registry title: Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke

Key facts

Where
Pittsburgh, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06303869, who can take part

Where in United States

  • University of PittsburghPittsburgh, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Jorge Gonzalez-Martinez
Trial code
NCT06303869
Record updated
8 May 2026
Original description
The goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The electrodes will be connected to external stimulators and a series of experiments will be performed to identify the types of movements that the hand and arm can make and how speech abilities are affected by the stimulation. The implant will be removed after less than 30 days. Results of this study will provide the foundation for future studies evaluating the efficacy of a minimally-invasive neuro-technology that can be used in clinical neuro-rehabilitation programs to restore speech and upper limb motor functions in people with subcortical strokes, thereby increasing independence and quality of life.Read full original descriptionShow less

Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke

The goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The electrodes will be connected to external stimulators and a series of experiments will be performed to identify the types of movements that the hand and arm can make and how speech abilities are affected by the stimulation. The implant will be removed after less than 30 days. Results of this study will provide the foundation for future studies evaluating the efficacy of a minimally-invasive neuro-technology that can be used in clinical neuro-rehabilitation programs to restore speech and upper limb motor functions in people with subcortical strokes, thereby increasing independence and quality of life.

Inclusion: Participants must have suffered a single, ischemic, or hemorrhagic stroke more than 6 months before the time of enrollment with dysarthria as a result; Participants must be between the ages of 18 and 75 years old. (Participants outside this age range may be at an increased medical risk and have an increased risk of fatigue during testing); English speaker; Participant must score ≤ 80% in at least 4 categories of the perceptual speech assessment (speech intelligibility, listener effort, speech naturalness, articulatory precision, speech rate, overall voice quality, and/or overall speech severity). OR ≤ 80% in at least 3 categories of the perceptual speech assessment AND ≤ 27 on the Communicative Participation Item Bank.

Exclusion: Participants must not be receiving anticoagulants; Participants must not be on anti-spasticity or anti-epileptic medications for the duration of the study; Medications with common cognitive side-effects; Patients with no clinical condition to undergo DBS implantation or highly dependent on anticoagulation therapy; Participants must not have any serious disease or disorder (ex. neurological condition other than stroke, cancer, severe cardiac or respiratory disease, renal failure, etc.) or cognitive impairments that could affect their ability to participate in this study; MRI contraindications (excluding subjects who are pregnant, who have metal in any portion of their body, have medical complications, cardiac pacemaker, cochlear implant, aneurysm clip, certain IUDs, or known problems of claustrophobia); Bleeding disorders or platelet dysfunction (e.g., from regular aspirin usage); Female participants of child-bearing age must not be pregnant, planning to become pregnant for the next 9 months, or breast feeding; Patients who refuse participation in the study; Patients with gross anatomical variances in MR imaging or cerebral vascular accidents involving thalamic and cerebellar areas; Patients who cannot undergo pre-operative MRIs or could not complete the pre-operative assessments; Severe claustrophobia; Participants who have been deemed inappropriate for participation based upon results from the Brief Symptoms Inventory (BSI-18) and discussions with the Principal Investigator and a study physician; Evaluation to sign consent form score \<12; Patients must not have any lesions in the lower motoneuron causing flaccid dysarthria.

ClinicalTrials.gov NCT06303869